Home » Newsletters » BioWorld

BioWorld

Jan. 25, 1994

View Archived Issues

BIOTECH SUMMIT DELIVERS IDEAS BUT NO AGENDA

INFLAZYME PARTNERSHIP FOR TB TEST

PHYTERA PRIVATE FINANCING RAISES $10.1M

APPOINTMENTS AND ADVANCEMENTS

RESEARCHERS DISCUSS SAFETY OF VIRAL VECTORS AT BIOEAST

GIBBONS PRAISES BIOTECH AT SUMMIT

SPARTA PHARMACEUTICALS FILES IPO TO RAISE $9.8M

GENPHARM GETS $3.1M FOR ANIMAL RESEARCH

HITACHI CHEMICAL CREATES GENE PROBE DESIGN BUSINESS

CORANGE MAKES INITIAL INVESTMENT IN CELLPRO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...